Taiwan Advance Bio-Pharmaceutical Inc. (TPEX:4186)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
10.15
-0.05 (-0.49%)
Jun 18, 2026, 2:39 PM CST
Market Cap913.50M -27.5%
Revenue (ttm)364.79M +3.0%
Net Income28.05M +22.6%
EPS0.31 +24.0%
Shares Out 90.00M
PE Ratio32.74
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume209,702
Open10.20
Previous Close10.20
Day's Range9.86 - 10.20
52-Week Range9.12 - 17.65
Beta0.36
Analystsn/a
Price Targetn/a
Earnings DateAug 13, 2026

About TPEX:4186

Taiwan Advance Bio-Pharmaceutical Inc. operates in the biotechnology industry in China, Germany, USA, Italy, Malaysia, Vietnam, Thailand, Indonesia, Japan, Korea, India, Pakistan, and internationally. The company provides food safety diagnostic testing kits; ELISA, rapid, and chemical test kits customization, and food safety lab establishment consultation services; and manufactures monoclonal and polyclonal antibody products. It also offers abused drugs rapid tests; provides cell banking services for newborn and adult stem cells storage; and op... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1989
Employees 160
Stock Exchange Taipei Exchange
Ticker Symbol 4186
Full Company Profile

Financial Performance

In 2025, TPEX:4186's revenue was 364.79 million, an increase of 3.00% compared to the previous year's 354.17 million. Earnings were 28.05 million, an increase of 22.61%.

Financial Statements